Spots Global Cancer Trial Database for A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
Official Title: A Multicenter, International, Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
Study ID: NCT03194893
Conditions
Study Description
Brief Summary: The purpose of this study is to provide continued treatment with alectinib or crizotinib as applicable to participants with ALK- or RET positive cancer who were previously enrolled in any Roche-sponsored alectinib study and who are deriving continued clinical benefit from alectinib or crizotinib in the parent trial at the time of parent trial closure.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Chao Family Comprehensive Cancer Center; UC Irvine Medical Center, Orange, California, United States
Miami Cancer Institute of Baptist Health, Inc., Miami, Florida, United States
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Guangdong General Hospital, Guangzhou, , China
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, , China
Shanghai Pulmonary Hospital, Shanghai, , China
Zhejiang Cancer Hospital, Zhejiang, , China
Centre Francois Baclesse, Caen, , France
Centre Georges François Leclerc; Service Pharmacie, Bp 77980, Dijon, , France
Centre Oscar Lambret, Lille, , France
Centre Leon Berard, Lyon, , France
Groupe Hospitalier Sud - Hôpital Haut Lévêque, Pessac, , France
Hopital Pontchaillou - CHU de Rennes, Rennes, , France
CHU de Toulouse - Hôpital Larrey; Service de pneumologie et oncologie pneumologique, Toulouse cedex 9, , France
Hopital Robert Schuman; Pneumologie, Vantoux, , France
Queen Mary Hospital; Dept. of Clinical Oncology, Hong Kong, , Hong Kong
Queen Elizabeth Hospital Department of Clinical Oncology, Kowloon, , Hong Kong
Irccs Centro Di Riferimento Oncologico (CRO); Dipartimento Di Oncologia Medica, Aviano, Friuli-Venezia Giulia, Italy
Azienda Ospedaliera San Camillo Forlanini - Unità Operativa Complessa di Pneumologia Oncologica 1, Roma, Lazio, Italy
Irccs Istituto Europeo di Oncologia (IEO); Divisione di Oncologia, Milano, Lombardia, Italy
Azienda Ospedaliero-Universitaria Careggi;S.C. Oncologia Medica 1, Firenze, Toscana, Italy
Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica, Perugia, Umbria, Italy
Seoul National University Hospital, Seoul, , Korea, Republic of
Samsung Medical Center, Seoul, , Korea, Republic of
Uniwersyteckie Centrum Kliniczne; Klinika Onkologii i Radioterapii, Gdansk, , Poland
FSBSI "Russian Oncological Scientific Center n.a. N.N. Blokhin", Moscow, Moskovskaja Oblast, Russian Federation
University ?linic of headaches, Moscow, Moskovskaja Oblast, Russian Federation
City Clinical Oncology Hospital, Moscow, Moskovskaja Oblast, Russian Federation
Hospital del Mar; Servicio de Oncologia, Barcelona, , Spain
Hospital Universitari Dexeus - Grupo Quironsalud; Servicio de Oncologia Medica, Barcelona, , Spain
Hospital Universitario La Paz; Servicio de Oncologia, Madrid, , Spain
Adana Ac?badem Hospital Oncology Department, Adana, , Turkey
Istanbul Uni Capa Medical Faculty; Inst. of Oncology, Istanbul, , Turkey
Ege University Medical Faculty; Chest Diseases, Izmir, , Turkey
Hacettepe Uni Medical Faculty Hospital; Oncology Dept, Sihhiye/Ankara, , Turkey
Contact Details
Name: Clinical Trials
Affiliation: Hoffmann-La Roche
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
